AzTrials
AzTrials

Urinary RetentionNCT05538273

Optimal Management of Urinary Catheter in Gyn Onc

An observational study of Urinary Retention, run by WellSpan Health at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This is a combined retrospective observational study that will collect data on urinary catheter removal of patients who underwent pelvic surgery by a gynecologic oncologist to assess timing safety and its implications in postoperative care. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Urinary Retention
What is being tested?
Early removal of urinary catheter postoperatively and Late removal of urinary catheter postoperatively
How many people
0 participants
Where
1 siteUnited States
Study dates
8 Sep 2022to 14 Mar 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: patients who meets the eligibility criteria, undergoing pelvic surgery by a gynecologic oncologist. Simple and radical procedures included.

Who may be able to join

  • Age above 18
  • female gender
  • undergoing pelvic surgery for benign or malignant indications by a gynecologic oncologist

Who cannot join

  • Age less than 18 years of age at the time of surgery
  • pregnant
  • individual is a prisoner

Trial locations and contacts

1 site in 1 country.

United States1 site
  • WellSpan York Hospital

    York, Pennsylvania, 17403

Other trials in United States

About this study

Official title: Optimal Management and Timing of Removal of Urinary Catheter Following Pelvic Surgery by the Gynecologic Oncology Surgeon

This is a combined retrospective observational study that will collect data on urinary catheter removal of patients who underwent pelvic surgery by a gynecologic oncologist to assess timing safety and its implications in postoperative care.

Being tested
Early removal of urinary catheter postoperatively, Late removal of urinary catheter postoperatively
Keywords
urinary retention, postoperative, urinary complications, pelvic surgery, hysterectomy, gynecologic oncology
Medical subject headings
Urinary Retention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early removal of urinary catheter postoperativelyOther

    removal of urinary catheter less than 24 hours after surgery

  • Late removal of urinary catheter postoperativelyOther

    removal of urinary catheter greater than 24 hours after surgery

Study groups in NCT05538273
Study groupRoleWhat they receive
Minimal invasive surgeryremoval of urinary catheter postoperatively
Receives: Other: Early removal of urinary catheter postoperatively; Other: Late removal of urinary catheter postoperatively
Laparotomyremoval of urinary catheter postoperatively
Receives: Other: Early removal of urinary catheter postoperatively; Other: Late removal of urinary catheter postoperatively
Simple surgeryremoval of urinary catheter postoperatively
Receives: Other: Early removal of urinary catheter postoperatively; Other: Late removal of urinary catheter postoperatively
Radical surgeryremoval of urinary catheter postoperatively
Receives: Other: Early removal of urinary catheter postoperatively; Other: Late removal of urinary catheter postoperatively

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Urinary retention rate after urinary catheter removal postoperatively

    urinary retention rate will be measured as need for re-catheterization postoperatively

    Measured: 30 days after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2022
  2. Study start8 Sep 2022
  3. Primary completion14 Mar 2023
  4. Study completion14 Mar 2023

Why it stopped: Study not activated, staff left institution.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05538273
Sponsor's protocol ID
1946054-1
Status last verified
Mar 2023
First submitted
8 Sep 2022
Last updated
17 Mar 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Urinary Retention, run by WellSpan Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 17 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Urinary retention rate after urinary catheter removal postoperatively (time frame: 30 days after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in